Concepedia

Roy L. Maute

RL

Statistics

Publications

15

Citations

5K

H-Index

15

Active since

2009

Affiliations

Stanford University(Current)

Columbia University

Yale University

The University of Texas MD Anderson Cancer Center

Cancer Genetics (United States)

Roy L. Maute is an author at Stanford University specializing in cancer immunotherapy, oncology, and immunotherapy.

ORCID

Publications per year

2009–2021

15

Publications

15

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity

Sydney R. Gordon, Roy L. Maute, Ben W. Dulken et al. · Nature · 2017 · 2.3K citations · Full text

, , +16

tRNA-derived microRNA modulates proliferation and the DNA damage response and is down-regulated in B cell lymphoma

Roy L. Maute, Christof Schneider, Pavel Sumazin et al. · Proceedings of the National Academy of Sciences · 2013 · 657 citations · Full text

, , +15

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy

Amira Barkal, Kipp Weiskopf, Kevin S. Kao et al. · Nature Immunology · 2017 · 558 citations · Full text

, , +16

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

Kipp Weiskopf, Nadine S. Jahchan, Peter J. Schnorr et al. · Journal of Clinical Investigation · 2016 · 431 citations · Full text

, , +13

Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging

Roy L. Maute, Sydney R. Gordon, Aaron T. Mayer et al. · Proceedings of the National Academy of Sciences · 2015 · 353 citations · Full text

, , +17

1–5 of 15